Position in XGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$264,101
+$48,713 QoQ
Shares Held
56,796
-20.9% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $26,693,573 across 9 Diagnostics & Research names. XGN ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
40,605 | $11,022,227 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
9,700 | $5,106,468 | |
| 3 | VCYT |
Veracyte, Inc.
|
59,958 | $3,521,333 | |
| 4 | PSNL |
Personalis, Inc.
|
239,000 | $3,202,600 | |
| 5 | NEO |
Neogenomics Inc
|
110,040 | $1,605,483 | |
| 6 | BDSX |
Biodesix Inc
|
44,618 | $1,006,135 | |
| 7 | MDXH |
MDxHealth SA
|
1,411,891 | $580,287 | |
| 8 | CSTL |
Castle Biosciences Inc
|
16,140 | $384,939 |
All Filings in XGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $264,101 | 56,796 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $215,388 | 71,796 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $112,936 | 18,575 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $220,624 | 20,075 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,618,368 | 231,858 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,518,465 | 422,971 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,737,256 | 423,721 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,417,911 | 458,871 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $897,844 | 493,321 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $784,777 | 493,571 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,012,720 | 508,905 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $638,650 | 263,905 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $765,324 | 263,905 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $631,569 | 259,905 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $605,772 | 252,405 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $697,703 | 257,455 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,360,236 | 236,975 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,613,829 | 200,975 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,319,894 | 199,475 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,804,728 | 206,230 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $3,005,195 | 200,480 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $3,561,775 | 203,530 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,747,086 | 132,355 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,304,648 | 120,355 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $1,333,381 | 83,650 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||